Abstract
Apoptosis is now recognized as a normal feature in the development of the nervous system and may also play a role in neurodegenerative disorders, such as Alzheimers disease. Cell surface receptors, caspases, mitochondrial factors or p53 participate in the modulation and execution of cell death. Therefore, the ability to understand and manipulate the cell death machinery is an obvious goal of medical research. Potential therapeutic approaches to modulate disease by regulating apoptosis are being tested, and include the traditional use of small molecules to target specific players in the apoptosis cascade. As our understanding of apoptosis increases, further opportunities will arise for more specific therapies that will result in improved efficacy. This review focuses on molecular mechanisms of apoptosis in Alzheimers disease and highlights the potential use of small molecule modulators to treat neurodegenerative disorders.
Keywords: Alzheimer's disease, Bcl-2 family, Caspases, Death receptors, Mitochondria, p53, Small molecules, Homeostasis, Apoptosis, Reactive oxygen species, Excitotoxicity, Neurodegeneration, Programmed cell death, Cytochrome, Parkinson's disease, Neurotrophic factors, Nerve growth factor, Basic fibroblast growth factor, Brain-derived neurotrophic factor, Amyloid plaques, Neurofibrillary tangles, Amyloid b, Tau proteins, Presenilin, Autophagy, Ursodeoxycholic acid, Tauroursodeoxycholic acid, Interleukin, VX-765, IDN-6556, LB-84451, Pralnacasan, ZVAD-fmk, Ac-YVAD-cmk, Z-DEVD-fmk, ZVAD-DCB, Caspase inhibitors, Humanin, Neuroprotection
Current Pharmaceutical Design
Title: Cell Death Targets and Potential Modulators in Alzheimers Disease
Volume: 16 Issue: 25
Author(s): Rui E. Castro, Maria M.M. Santos, Paulo M.C. Gloria, Carlos J.A. Ribeiro, Duarte M.S. Ferreira, Joana M. Xavier, Rui Moreira and Cecilia M.P. Rodrigues
Affiliation:
Keywords: Alzheimer's disease, Bcl-2 family, Caspases, Death receptors, Mitochondria, p53, Small molecules, Homeostasis, Apoptosis, Reactive oxygen species, Excitotoxicity, Neurodegeneration, Programmed cell death, Cytochrome, Parkinson's disease, Neurotrophic factors, Nerve growth factor, Basic fibroblast growth factor, Brain-derived neurotrophic factor, Amyloid plaques, Neurofibrillary tangles, Amyloid b, Tau proteins, Presenilin, Autophagy, Ursodeoxycholic acid, Tauroursodeoxycholic acid, Interleukin, VX-765, IDN-6556, LB-84451, Pralnacasan, ZVAD-fmk, Ac-YVAD-cmk, Z-DEVD-fmk, ZVAD-DCB, Caspase inhibitors, Humanin, Neuroprotection
Abstract: Apoptosis is now recognized as a normal feature in the development of the nervous system and may also play a role in neurodegenerative disorders, such as Alzheimers disease. Cell surface receptors, caspases, mitochondrial factors or p53 participate in the modulation and execution of cell death. Therefore, the ability to understand and manipulate the cell death machinery is an obvious goal of medical research. Potential therapeutic approaches to modulate disease by regulating apoptosis are being tested, and include the traditional use of small molecules to target specific players in the apoptosis cascade. As our understanding of apoptosis increases, further opportunities will arise for more specific therapies that will result in improved efficacy. This review focuses on molecular mechanisms of apoptosis in Alzheimers disease and highlights the potential use of small molecule modulators to treat neurodegenerative disorders.
Export Options
About this article
Cite this article as:
E. Castro Rui, M.M. Santos Maria, M.C. Gloria Paulo, J.A. Ribeiro Carlos, M.S. Ferreira Duarte, M. Xavier Joana, Moreira Rui and M.P. Rodrigues Cecilia, Cell Death Targets and Potential Modulators in Alzheimers Disease, Current Pharmaceutical Design 2010; 16 (25) . https://dx.doi.org/10.2174/138161210793176563
DOI https://dx.doi.org/10.2174/138161210793176563 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ketamine: New Indications for an Old Drug
Current Drug Targets A Study on Identification of Nutraceutical Value of New Imidazolone Schiff Base Analogues
Letters in Drug Design & Discovery Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD
Current Alzheimer Research Recent Advances in the Development of Selective Ligands for the Cannabinoid CB2 Receptor
Current Topics in Medicinal Chemistry Recent Patents in Diagnosis and Treatment for Inborn Errors of Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets A New Interpretative Paradigm for Conformational Protein Diseases
Current Protein & Peptide Science Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry The Challenges in Moving from Ageing to Successful Longevity
Current Vascular Pharmacology Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimers Disease
Current Pharmaceutical Design Editorial (Thematic Issue: NAD<sup>+</sup> Biosynthesis and Signaling as an Emerging Area in Medicinal Chemistry)
Current Topics in Medicinal Chemistry Alzheimer’s Disease: A Contextual Link with Nitric Oxide Synthase
Current Molecular Medicine <i>In Silico</i> Insight into the Inhibitory Effects of Active Antidiabetic Compounds from Medicinal Plants Against SARS-CoV-2 Replication and Posttranslational Modification
Coronaviruses Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research
Current Drug Targets The Extra-Hematopoietic Role of Erythropoietin in Diabetes Mellitus
Current Diabetes Reviews Role of Nicotinic Acetylcholine Receptors in Cardiovascular Physiology and Pathophysiology: Current Trends and Perspectives
Current Vascular Pharmacology Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Differences in Relative Levels of 88 microRNAs in Various Regions of the Normal Adult Human Brain
MicroRNA Age-Related Increase in Levels of 5-Hydroxymethylcytosine in Mouse Hippocampus is Prevented by Caloric Restriction
Current Alzheimer Research Metal Complexes of Biologically Active Ligands as Potential Antioxidants
Current Medicinal Chemistry